Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Kestra Medical Technologies (KMTS) Operating Expenses (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Operating Expenses for 3 consecutive years, with $47.7 million as the latest value for Q1 2026.

  • Quarterly Operating Expenses rose 75.6% to $47.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $184.4 million through Jan 2026, up 91.13% year-over-year, with the annual reading at $130.6 million for FY2025, 52.87% up from the prior year.
  • Operating Expenses for Q1 2026 was $47.7 million at Kestra Medical Technologies, up from $43.2 million in the prior quarter.
  • The five-year high for Operating Expenses was $55.8 million in Q2 2025, with the low at $20.8 million in Q1 2024.
  • Average Operating Expenses over 3 years is $33.5 million, with a median of $27.1 million recorded in 2025.
  • Peak annual rise in Operating Expenses hit 156.81% in 2025, while the deepest fall reached 30.36% in 2025.
  • Over 3 years, Operating Expenses stood at $25.0 million in 2024, then skyrocketed by 72.97% to $43.2 million in 2025, then increased by 10.4% to $47.7 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods came in at $47.7 million, $43.2 million, and $37.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.